Phase 3 Pancreatitis Trial, Recruiting (NCT07441824)

Phase 3 Pancreatitis Trial, Recruiting NCT07441824 Sponsor: Asian Institute of Gastroenterology, India Condition: Pancreatitis

Printed from Voxsanity (voxsanity.com.au) — NCT07441824 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pancreatitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with a specific type of sudden pancreas inflammation (acute pancreatitis) using standard medical guidelines
More than half of your pancreas tissue has been damaged/died, and you have lost at least 5% of your body weight since becoming ill
You are within 6 weeks of when your illness first started
You are able to eat and drink by mouth
You are between 18 and 60 years old
You can be of any gender

Who may not be able to join:

You have a long-term, ongoing pancreas condition (chronic pancreatitis)
You have had repeated episodes of sudden pancreas inflammation in the past (recurrent acute pancreatitis)
You have been diagnosed with pancreatic cancer
You are being sent home from hospital with a feeding tube that goes through your nose into your small intestine
You are currently pregnant or breastfeeding
You are unable to give your own agreement to take part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Rupjyoti Talukdar, MD, Asian Institute of Gastroenterology Hospitals

Phone: +919652104726

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07441824

Sponsor: Asian Institute of Gastroenterology, India

Phase: Phase 3

Status: Recruiting

Condition: Pancreatitis

Trial contact: +919652104726

More information: https://clinicaltrials.gov/study/NCT07441824

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with a specific type of sudden pancreas inflammation (acute pancreatitis) using standard medical guidelines
More than half of your pancreas tissue has been damaged/died, and you have lost at least 5% of your body weight since becoming ill
You are within 6 weeks of when your illness first started
You are able to eat and drink by mouth
You are between 18 and 60 years old
You can be of any gender

Who may not be able to join:

You have a long-term, ongoing pancreas condition (chronic pancreatitis)
You have had repeated episodes of sudden pancreas inflammation in the past (recurrent acute pancreatitis)
You have been diagnosed with pancreatic cancer
You are being sent home from hospital with a feeding tube that goes through your nose into your small intestine
You are currently pregnant or breastfeeding
You are unable to give your own agreement to take part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 3

Sponsor

Asian Institute of Gastroenterology, India

Registry

ClinicalTrials.gov

Start date

10 April 2026

Est. completion

1 June 2027

Where this trial is recruiting

🇮🇳 India

Primary endpoints

Percent change in body weight

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov